The other frequently mutated genes, such as SYNE1, MUC16, etc. have been found to be mutated in other cancer types and may be novel candidate driver mutations in early stage of CRC tumorigenesis [20,21]. The gene discussed is SYNE1; the disease is colorectal carcinoma.